Dallas Formulations Private Limited - Company Profile

It is a pharma private limited company based in Ujjain, Madhya Pradesh, India, established in 2000.
2000 Ujjain, Madhya Pradesh, India Active
Last Updated:
Access Report
About Dallas Formulations Private Limited

Dallas Formulations Private Limited, a active private limited company, was established on 24 November 2000 in Ujjain, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233MP2000PTC014476. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.91 M.

Formerly known as Chirayu Ayurveda Private Limited. It upholds a compliant status. Employing 22 professional, Its leadership includes Rajesh Gupta (Director), Mukesh Kumar (Whole-Time Director). Past directors included Jambukumar Jain, Nandkishore Maheshwari, Anil Kumar. It holds ₹2.66 Cr open charges and ₹5.24 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 220,Block-C, 2Nd Floor Madhav Club Road, Dawa Bazar, Ujjain, Madhya Pradesh, 456010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MP2000PTC014476

  • Registration Number

    014476

  • Incorporation Date

    24 November 2000

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹3.91 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 3.91 M
  • Company Age 25 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.66 Cr
  • Satisfied Charges ₹ 5.24 Cr
  • Revenue Growth **** -6.75%
  • Profit Growth **** 501.87%
  • Ebitda **** 18.82%
  • Net Worth 4.20%
  • Total Assets **** 4.27%
Company report

Dallas Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dallas Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dallas Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Gupta Director 16 Jan 2006 Current
Mukesh Kumar Whole-Time Director 21 Jul 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Jul 2015 Past
Pramod Abcsdd Director 04 Oct 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dallas Formulations.

Dallas Formulations Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.75% decrease. The company also saw a substantial improvement in profitability, with a 501.87% increase in profit. The company's net worth moved up by a moderate rise of 4.2%.

Dallas Formulations revenue growth over time
Dallas Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -6.75%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.27%
*******
*******
*******
*******
Total Assets
*******
 4.27%
*******
*******
*******
*******
Profit or Loss
*******
 501.87%
*******
*******
*******
*******
Net Worth
*******
 4.20%
*******
*******
*******
*******
EBITDA
*******
 18.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dallas Formulations?

In 2024, Dallas Formulations had a public holding of 40.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹26,600,000.00

Satisfied Charges

₹52,406,912.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 2.66 Cr
Latest Charge Details
Date Lender Amount Status
11 Nov 2006 State Bank Of India ₹2.66 Cr Open
28 Nov 2013 Ing Vysya Bank Limited ₹1.75 Cr Satisfied
17 Aug 2011 Dir. Of Industries With Parri Passu Sbi Baddi ₹1.29 Cr Satisfied
29 Apr 2006 State Bank Of India ₹2.20 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Dallas Formulations?

Dallas Formulations has a workforce of 22 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dallas Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dallas Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dallas Formulations
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 17 Aug 2011 via Charge ID 10302287 with Dir. Of Industries With Parri Passu Sbi Baddi was fully satisfied on 22 Apr 2025. was completed.

  • Annual General Meeting

    The activity Dallas Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Dallas Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 26.60 M registered on 11 Nov 2006 with Charge ID 10030257 was modified on 15 May 2023. was documented.

  • Director Appointment

    Progress on Mukesh Kumar was appointed as a Whole-time director was appointed as a Whole-time director on 21 Jul 2022 & has been associated with this company since 3 years 6 months . was documented.

  • Charges

    The activity A charge registered on 28 Nov 2013 via Charge ID 10466437 with Ing Vysya Bank Limited was fully satisfied on 29 Oct 2014. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dallas Formulations Private Limited?

The CIN of Dallas Formulations Private Limited is U24233MP2000PTC014476.

Where is Dallas Formulations Private Limited headquartered?

Dallas Formulations Private Limited is headquartered at 220,Block-C, 2Nd Floor Madhav Club Road, Dawa Bazar, Ujjain, Madhya Pradesh, 456010.

When was Dallas Formulations Private Limited incorporated?

Dallas Formulations Private Limited was incorporated on 24 November 2000.

Who are the current directors of Dallas Formulations Private Limited?

The current directors of Dallas Formulations Private Limited are

What is the primary industry of Dallas Formulations Private Limited?

The primary industry of Dallas Formulations Private Limited is Manufacturing.

Is Dallas Formulations Private Limited a listed company?

Dallas Formulations Private Limited is unlisted.

What is the capital structure of Dallas Formulations Private Limited?

The authorized capital of Dallas Formulations Private Limited is ₹5.00 M, and the paid-up capital is ₹3.91 M.

What is the compliance status of Dallas Formulations Private Limited?

The compliance status of Dallas Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available